{
  "pmcid": "10085918",
  "sha256": "b8ecbbbf8199d715c0fddbaf45032c3767cadef7d6c85bb874c3e500b1f759e0",
  "timestamp_utc": "2025-11-09T23:03:51.515158+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.717419562419568,
    "reading_ease": 8.004795152295173,
    "word_count": 259
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Perioperative Systemic Therapy Versus CRS–HIPEC Alone in Resectable Colorectal Peritoneal Metastases"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "adults with isolated resectable colorectal peritoneal metastases"
      },
      "Intervention": {
        "score": 2,
        "evidence": "perioperative systemic therapy versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS–HIPEC) alone"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated patient-reported outcomes (PROs)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "PROs were assessed using EORTC QLQ-C30, QLQ-CR29, and EQ-5D-5L questionnaires at baseline, after neoadjuvant treatment, and at 3 and 6 months postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomised 1:1"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From June 2017 to January 2019, 80 patients were randomised, with 40 in each group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "In the modified intention-to-treat analysis, 37 patients received perioperative systemic therapy and 42 underwent upfront surgery."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The experimental arm experienced worsening of fatigue (MD +14, p = 0.001), loss of appetite (MD +15, p = 0.003), hair loss (MD +18, p < 0.001), and loss of taste (MD +27, p < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT02758951."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}